Genetic moderators of naltrexone's effects on alcohol cue reactivity. - Wikidata - wikimedia - TriplyDB

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

http://www.wikidata.org/entity/Q51791744

about

The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review Endogenous opiates and behavior: 2006 Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Dopamine D4 receptor gene variation is associated with context-dependent attention for emotion stimuli Proton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype?Pharmacogenetics of OPRM1.Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.Pharmacogenetics of alcohol and alcohol dependence treatment Effects of opioid receptor gene variation on targeted nalmefene treatment in heavy drinkers.Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.The pharmacogenetics of alcohol use disorder A human laboratory pilot study with baclofen in alcoholic individuals Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review.Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults.Interaction between the DRD4 VNTR polymorphism and proximal and distal environments in alcohol dependence during emerging and young adulthood.The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects.Effects of craving and DRD4 VNTR genotype on the relative value of alcohol: an initial human laboratory study.Ambulatory monitoring in the genetics of psychosomatic medicine.Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment.Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.Effects of a context shift and multiple context extinction on reactivity to alcohol cues.Initial evidence of an association between OPRM1 and adolescent alcohol misuse Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.OPRM1 and diagnosis-related posttraumatic stress disorder in binge-drinking patients living with HIV.The genetics of the opioid system and specific drug addictions Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.Use of novel technology-based techniques to improve alcohol-related outcomes in clinical trials.Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network.Role of the HPA axis and the A118G polymorphism of the mu-opioid receptor in stress-induced drinking behavior.Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.Pharmacological approaches to reducing craving in patients with alcohol use disorders.Nalmefene for treatment of alcohol dependence.Experimental medicine in drug addiction: towards behavioral, cognitive and neurobiological biomarkers.Pharmacogenetics of alcohol, nicotine and drug addiction treatments.Pharmacogenomics of the human µ-opioid receptor.

P2860

Q24616528-D52E2808-C2CF-41EF-9235-93680B790F2B Q28752585-3A831416-4F23-469F-B19A-1E4DFEAB6638 Q30440516-9513E843-7BC5-427A-B235-BA861ACD1028 Q30448177-0725E80F-D2D4-4852-8A29-82643A7914C7 Q31158547-FAA73911-178D-4880-A3B1-616290EB94F8 Q33568294-875E3B92-311E-42B4-A2E3-DDB91479CBD7 Q33797971-6F96033A-D113-4506-9406-7CFF40F1ED44 Q33813158-BEF00B58-2C7F-4B4B-9C10-E31DE4A1E4A2 Q33828177-F50CB09B-463B-4CBA-8656-28546D73845D Q33921223-3F597991-BB63-463E-93E8-9FFC33485CB6 Q34081709-A511DA5D-EC4E-4671-8B52-01E835988407 Q34180425-CF411AA3-9215-44AE-AAE7-020514ED411F Q34311649-D0589680-255A-45B5-8DF3-B121C3CAEC3E Q34463974-539447BA-82FF-4F7A-AE8F-52A3839E47B8 Q34871492-E136D1F8-FB26-4FE7-B031-D60594515DF7 Q34941455-20FF3A14-A288-48BB-B5B7-9605AE12FBA6 Q34972111-FFFD6155-3415-4A40-8BA2-338D15AB40DE Q34989821-A41C3E55-694B-405B-944C-5A846E6ED807 Q35116168-70F682DC-88AB-4F81-AAB0-C4CB851FA08C Q35151789-F84238F4-D62F-4307-8AA3-5E22A8D03AA1 Q35651859-BB53CC54-4ADF-414B-8455-F7CA65A4FF42 Q36041596-E19FD5D6-7BFA-4E59-9E86-496E86AC7434 Q36322822-C513F39A-77D4-406E-A87F-85358B955ACE Q36476979-7EDEC1FF-9C0E-46B5-AD16-5F726517F059 Q36540015-85A4908F-71E6-48D2-8A49-07D4B8B42C79 Q36882328-4D737F40-815B-44DD-8597-3D3FAFC375F6 Q36952699-034A40B5-C7A7-4D1B-BAD2-CFF1CCDCE9D5 Q36989434-BED3FEE4-41D0-44AC-827C-DB3F450510FD Q37012052-47EE2266-FE80-4EBD-9591-E72B274B88F7 Q37040492-EABF0C1F-78A4-4DDF-B4B8-1D393D960192 Q37089324-95655E5F-9260-402C-AC7D-4E53B06D518C Q37276159-D01907C1-C6FF-4907-8A57-384B53B1F524 Q37311980-DD8792BB-23F2-4E60-BC5F-178DD58CB0B7 Q37321330-840B5C46-0ABC-43C7-B7E7-B3C521D4F402 Q37344738-503EFDD8-ABC9-48EB-AA73-E9BBD130F6CE Q37708082-914CAF67-9079-4F2C-A477-A630388AEAB5 Q37792101-0A265649-C5F8-4DFC-BBDC-3AF2F742CC7A Q37822217-029BDF02-1292-4979-82E9-746AFD988180 Q37848476-AF708F0E-9660-413A-95B9-CD2E97D93E9E Q37932516-D4707C38-176F-446C-AF27-DAD7137F0E1D

P2860

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

http://www.wikidata.org/entity/Q51791744

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

@en

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

@nl

type

label

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

@en

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

@nl

prefLabel

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

@en

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

@nl

P1433

Q51791744-961FEB2A-9E63-4EA2-9CCD-BB3183441178

P1476

Q51791744-2B88F80D-EBC4-4251-BFB9-78BDB92C1317

P2093

Q51791744-28152D06-6165-4774-909F-5B35C5CEE641

Q51791744-50629C65-0C51-438A-8B85-1FDD4F30D190

Q51791744-55CC6A25-885D-4965-B0C5-D8E8A00B0A22

Q51791744-67931340-B373-4D7E-9DCD-8BD9725163FC

Q51791744-684EE815-3EB4-4DF6-B72D-10E737943046

Q51791744-9E3D3800-25E6-42D9-9C06-7A6A6ADC5524

P2860

Q51791744-035755E8-3BFE-4766-9506-64D2141F6F94

Q51791744-062E19AC-5F5B-46AB-A0F7-E57515802114

Q51791744-1BF4477F-A591-47A9-A0AB-C4C77AB7D5BD

Q51791744-1E05D2F0-0A70-461E-BB66-FE7F3C0B57DE

Q51791744-238D136F-0989-4A07-8478-E3F9D8761184

Q51791744-282F78D6-9266-4E5C-A97E-BDCE347F4257

Q51791744-2BD95F90-7490-4F47-A4EB-DB63762245D3

Q51791744-2F7023FA-A2DC-4D35-B385-1A4867F488DF

Q51791744-34D63277-0817-45ED-AE27-346E23450B60

Q51791744-4EC73EE8-12DC-44B1-964C-8C44F6A148FA

P304

Q51791744-F6A02428-94B9-4358-9DF6-3186439817EA

P31

Q51791744-DFB25C35-FA86-405F-95B0-99764330C206

P356

Q51791744-9C5730B4-4A82-4BD7-9E79-A538081B01F2

P433

Q51791744-9A5E9586-2C8B-4168-9474-F1E8D510C9BB

P478

Q51791744-276A86BB-5353-4D1E-96AC-5A297C886072

P577

Q51791744-64CB34D4-7F94-44C1-BD1A-2DBFE8DB7BAD

P698

Q51791744-3AD5B330-2566-4E0E-8E3E-8078139A2E49

P921

Q51791744-6FBA2212-9F92-4D99-BECA-6D1F177DC4D5

P356

J.1530-0277.2006.00156.X

P1433

Alcoholism: Clinical and Experimental Research

P1476

Genetic moderators of naltrexone's effects on alcohol cue reactivity.

@en

P2093

Damaris J Rohsenow

http://www.w3.org/2001/XMLSchema#string

Jennifer Tidey

http://www.w3.org/2001/XMLSchema#string

John E McGeary

http://www.w3.org/2001/XMLSchema#string

Peter M Monti

http://www.w3.org/2001/XMLSchema#string

Robert Miranda

http://www.w3.org/2001/XMLSchema#string

Robert Swift

http://www.w3.org/2001/XMLSchema#string

P2860

Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling.

Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men.

What place does naltrexone have in the treatment of alcoholism?

Craving: consensus of status and agenda for future research.

Relevance of cue reactivity to understanding alcohol and smoking relapse.

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor.

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.

Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride.

P304

1288-1296

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1530-0277.2006.00156.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16899031

http://www.w3.org/2001/XMLSchema#string

P921